DOW JONES22,679.99+1627.46 7.73%
S&P 5002,663.68+175.03 7.03%
NASDAQ7,913.24+540.16 7.33%

B of A Securities Initiates Coverage On Intercept Pharmaceuticals with Neutral Rating, Announces $111 Price Target

B of A Securities analyst Geoff Meacham initiates coverage on Intercept Pharmaceuticals (NASDAQ:ICPT) with a Neutral rating and a $111 price target.

Benzinga · 03/05/2020 11:32

B of A Securities analyst Geoff Meacham initiates coverage on Intercept Pharmaceuticals (NASDAQ:ICPT) with a Neutral rating and a $111 price target.